SpyFu guide: How to get the most out of this SEO tool
Master SpyFu with Backlinko's comprehensive guide. Uncover your competitors' strategies, keywords, and ad campaigns with ease.
Master SpyFu with Backlinko's comprehensive guide. Uncover your competitors' strategies, keywords, and ad campaigns with ease.
Want to get the most out of SimilarWeb? This in-depth guide will show you how to boost your SEO and content marketing campaigns with SimilarWeb.
Your SEO tools already contain the answers. MCP makes it easier to ask questions your dashboards weren't built to handle.
Learn how to structure, localize, and optimize your website for international audiences. This guide covers hreflang, geotargeting, multilingual SEO, and more.
Google's June core update overall was a bigger update; where some sites hit by the previous helpful content and reviews updates some partial recoveries.
Now that the March 2025 core update is done rolling out, we can compare it to the previous core updates - and it seemed pretty similar to the December 2024 core update.
This last Google core update was more impactful than the November core update but not the August or March 2024 core updates.
This last Google core update was less impactful than the August core update and some other core updates.
Google said the March 2024 core update was their biggest core update but the August 2024 core update did shake things up, in a big way.
Keep in mind, the November 2023 Reviews update overlapped with this core update and is still rolling out.
This was a very big set of Google updates, here is an analysis.
Overall, the tools did not show as much volatility with the helpful content update than it did with core updates - but this was a big update.
Discover how quality links can elevate a website's credibility and boost rankings with no shortcuts – just straightforward strategies
This quick guide shows how to use the popular AI chatbot to support your link building processes and campaigns.
See the results of a comparison of four leading SEO tools' keyword coverage for domains in the pharmaceutical space.